# Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer

> **NCT04156360** · — · UNKNOWN · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 150 (estimated)

## Conditions studied

- Healthy
- Pulmonary Nodule

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04156360
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2020-11-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04156360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04156360, "Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT04156360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*